Endocrinology Vol. 138, No. 10 4351-4357
Copyright © 1997 by The Endocrine Society
Emergence of an Isolated Arginine Vasopressin (AVP) Response to Stress after Repeated Restraint: A Study of Both AVP and Corticotropin-Releasing Hormone Messenger Ribonucleic Acid (RNA) and Heteronuclear RNA1
Xin-Ming Ma2,
Andrew Levy and
Stafford L. Lightman
Dorothy Crowfoot Hodgkin Laboratories, Department of Medicine,
University of Bristol, Bristol BS2 8HW, United Kingdom
Address all correspondence and requests for reprints to: Stafford Lightman, Ph.D., Dorothy Crowfoot Hodgkin Laboratories, Department of Medicine, University of Bristol, Marlborough Street, Bristol BS2 8HW, United Kingdom. E-mail: Stafford.Lightman{at}bristol.ac.uk
 |
Abstract
|
|---|
The hypothalamic-pituitary-adrenal axis adapts to periods of chronic or
repeated stress. We have now investigated whether there is any
differential effect of repeated immobilization stress on CRH and
arginine vasopressin (AVP) gene transcription in the hypothalamic
paraventricular nucleus (PVN), using probes for both intronic and
exonic sequences of the AVP and CRH genes. Daily restraint for 13 days
had no significant affect on basal corticosterone level, CRH
heteronuclear RNA (hnRNA), CRH messenger RNA (mRNA), AVP hnRNA, or AVP
mRNA. After the final episode of acute restraint, on day 14, there was
a rapid increase in plasma corticosterone and AVP hnRNA level in the
parvocellular subdivision of the PVN, a slower increase in AVP mRNA
level in the parvocellular subdivision of the PVN, but no significant
change in either CRH hnRNA or CRH mRNA in the PVN. The increase in AVP
hnRNA and mRNA was specific to the parvocellular PVN, because there was
no change in either transcript in the magnocellular cells of this
nucleus. This isolated response is in marked contrast to naive rats,
which show a predominant CRH hnRNA and mRNA response, and infers that
part of the adaptation to repeated stress results from a
down-regulation of CRH gene responsiveness with maintenance or even a
compensatory increase in the AVP gene response.
 |
Introduction
|
|---|
ALTHOUGH both CRH and arginine vasopressin
(AVP) from the parvocellular cells of the paraventricular nucleus (PVN)
are known to stimulate ACTH secretion (1, 2), CRH is accepted to be the
most important factor in mediating the stress response (3, 4, 5). AVP is
colocalized in up to 50% of CRH-positive neurons in the PVN under
normal resting conditions (6, 7) and acts both as a weak ACTH
secretagogue on its own, and synergistically with CRH (8, 9, 10, 11, 12). It has
been repeatedly demonstrated that acute stress results in increased
levels of CRH messenger RNA (mRNA) in the PVN (13, 14, 15, 16, 17, 18, 19, 20). Changes of AVP
mRNA in the parvocellular subdivision of the PVN, in response to acute
stress, are less marked but nonetheless do occur (13, 21, 22, 23). However,
the response of CRH mRNA to repeated and chronic stresses is much more
complex. Depending on the stimulus used, CRH mRNA in the PVN may
increase (19, 24, 25, 26, 27, 28, 29), decrease (30), or remain unchanged (14).
Adaptation of the CRH mRNA response rapidly appears after repeated
restraint stress (14), as does desensitization of the pituitary ACTH
response (31, 32). On the other hand, repeated stress is associated
with a sensitization of corticotropes to AVP (33), and there is
evidence for a role of AVP in sustaining hypothalamic-pituitary-adrenal
(HPA) responsiveness in the rat (9). Furthermore, there is now evidence
that AVP has a specific role in repeated and chronic stress paradigms
(30, 34, 35).
Recent studies have demonstrated that CRH heteronuclear RNA (hnRNA) and
AVP hnRNA levels in the PVN increase rapidly in response to acute
stress (23, 36, 37, 38). Because of the very short half-life of hnRNA,
these changes reflect gene transcription much better than the more
stable mRNA. We have recently published a detailed time course of the
CRH and AVP hnRNA and mRNA responses to acute restraint stress (20) and
have now gone on to detail how this response changes in animals
previously exposed to 13 days of daily restraint.
 |
Materials and Methods
|
|---|
Adult male Wistar rats, weighing 225250 g, were divided into
nine groups (n = 6 or 7). One control group of animals was simply
handled daily and killed on the morning of day 14. One group was
restrained daily for 90 min for 13 days and killed without further
restraint on day 14. The other 7 groups were restrained daily for 13
days and on day 14 all had a final episode of restraint. Four groups
were removed after 15, 30, 60, and 90 min of restraint and were killed
immediately. The final three groups were returned to their home cages
after 90 min restraint and killed at 2, 3, and 4 h after the start
of restraint (equivalent to 1/2, 1 1/2, and 2 1/2 h after the return to
their home cages).
Animals were killed by decapitation. Trunk blood was collected into
heparinized tubes and the brains removed and frozen on dry ice. Then
12-µm sections were cut through the medial parvocellular division of
the PVN and thaw mounted on twice-gelatin-coated slides and stored at
-80 C. Before hybridization, sections were air dried at room
temperature and fixed with 4% formaldehyde for 5 min at room
temperature, washed 3 times with PBS, and then incubated in 0.25%
acetic anhydride in 0.1 M triethanolamine/0.9% NaCl (pH
8.0) for 10 min at room temperature. Sections were transferred through
70 (1 min), 80 (1 min), 95 (2 min), and 100% ethanol (1 min); 100%
chloroform (5 min); and 100 (1 min) and 95% ethanol (1 min); and
dried. All control and experimental sections were hybridized in the
same hybridization reaction.
The AVP intronic probe, a synthetic 36-base oligonucleotide
corresponding to the first 36 bases of rat AVP intron I (AVPin) (39),
was made, as described (20). The AVP exonic probe (AVPex) was a 48-base
oligonucleotide complementary to part of the exonic mRNA sequence
coding for AVP. The specificity of AVPin (36, 40) and AVPex (40) probes
has previously been determined. The probes were labeled with
35S-deoxyATP, as previously described (20). The
hybridization procedures were carried out, as previously described (13, 40). In brief, sections were hybridized overnight at 37 C with 5
x 105 cpm labeled AVPin or 3 x 105 cpm
AVPex probe per 2 sections, then washed in four 15-min rinses of 1
x SSC (1 x SSC = 0.15 M NaCl and 0.015
M sodium citrate, pH 7.0) on shaking waterbath (55 C),
followed by two 30-min rinses in 1 x SSC at room temperature.
The rat CRH intron (CRHin) probe was generated from a 530-bp pvuII
fragment of the CRH gene subcloned into PGem 3 and linearized by
XbaI (which was kindly supplied by Dr. Bob Thompson). The
rat CRH (CRHex 2) complementary DNA (41) used same source with CRHin)
was a 770-bp BamH1 fragment subcloned in PGem3Z, linearized by
HindIII. The 35S-labeled cRNA probes for CRHin
and CRHex were produced as previously described (20). The specificity
of CRHin and CRHex probes was confirmed by sense-strand cRNA probes,
respectively (42). Sections were hybridized at 55 C with 1 x
106 cpm-labeled CRHin or CRHex probe per slide containing 2
sections; and then nonspecifically hybridized probe was removed by
washing 2 times with 2 x SSC containing 50% formamide at 50 C,
incubated with ribonuclease A for 30 min at 37 C, followed by 2
washings 3 times with 2 x SSC containing 50% formamide at 50 C,
and 2 times with 2 x SSC at room temperature for 10 min. Finally,
slides were dipped in water and air dried.
Plasma corticosterone assays
Total plasma corticosterone was determined in plasma (5 µl
diluted in 500 µl buffer) by RIA as described previously (16).
125I-corticosterone was used as the tracer with a specific
activity of 23 mCi/mg. Corticosterone antibody was a kind gift of Dr.
Gabor Makara, Budapest. The sensitivity of the assay was 25 ng/ml.
Analysis and quantification
For quantification of CRH hnRNA and CRH mRNA in the PVN, the
sections and 14C-labeled standards of known radioactivity
(American Radiochemical, St. Louis, MO) were placed in x-ray cassettes,
then exposed to Hyperfilm MP autoradiography film (Amersham
International Plc, Amersham, UK) for 3 days (CRHex) and 15 days
(CRHin). For cellular localization of AVP and CRH hybrids, the slides
were subsequently dipped in nuclear emulsion (Ilford Scientific Product
K-5, Ilford, Essex, UK) and exposed for appropriate times (AVPin, 50
days; AVPex, 9 days; CRHin, 35 days; CRHex, 12 days). The slides were
counterstained with cresyl violet acetate (Sigma, Dorset, UK). The
optical density of autoradiographic images was measured by using a
computerized image analysis system, as described (16). In brief, the
autoradiographic image of probe bound to parvocellular CRH mRNA and CRH
hnRNA, together with 14C-labeled standards, were measured
using a computerized image analysis system (Image 1.22, developed by W.
Rasband, NIH) on an Apple Mac IICi computer. The optical densities were
obtained in two consecutive sections per rat, the average value for
each rat was used to calculate group means, and the results are
presented as means percentage change from control with SEM.
Analysis of changes in the prevalence of AVP transcripts in the medial
parvocellular and posterior magnocellular subdivisions of the PVN was
carried out in the cresyl violet counterstained sections using a x40
objective for AVP mRNA and a x100 oil immersion objective for AVP
hnRNA, with brightfield condenser, as described (20, 23). Briefly, the
medial parvocellular AVP neurons in the PVN were differentiated
histologically from magnocellular neurons on the basis of their overall
size, their relatively low level of AVP expression, and their small,
dense-staining nuclei. Magnocellular cells in the medial parvocellular
subdivision were characterized by large numbers of superimposed silver
grains, relatively faint nuclear and Nissl cytoplasmic staining, and
their large size. The neurons in the medial parvocellular subdivision
of the PVN were considered to be positive for AVP hnRNA if overlying
grain densities were at least three times that of background, measured
in the vicinity of the labeled cells. The relative levels of AVP hnRNA
and mRNA were quantified in the medial parvocellular and posterior
magnocellular subdivisions of PVN using computerized densitometry, as
described above on coronal sections, subtracting background from the
proximity of the measured cells. Scattered magnocellular cells in the
medial parvocellular subdivision of the PVN were excluded from the
analysis on the basis of their histological appearance. For each
animal, at least 4 PVNs on two sections were assessed; the average
value of each section for each rat was used to calculate group means.
The results are presented as means percentage change from control with
SEM.
Statistical analysis was performed by one-way ANOVA, followed by the
Fisher least significant difference procedure (PLSD) test, to assess
statistical significance between the control and experimental groups at
each time point. P < 0.05 was considered to be
statistically significant.
 |
Results
|
|---|
Plasma corticosterone
There was no significant difference between basal corticosterone
level, after 13 days repeated stress, and the level found in the
control group of rats. After immobilization, the repeatedly immobilized
animals still showed a prompt release of corticosterone, which peaked
at 15 min and remained raised at 90 min before returning to basal
levels (Fig. 1
), although the levels
themselves were less than those seen in the control animals (control
animals: time 0 min, 62.6 ± 12.3; 30 min, 569.62 ± 41.9; 60
min, 522.9 ± 48.9; 120 min, 41.9 ± 5.03 ng/ml) (repeatedly
immobilized animals: time 0 min, 73.7 ± 11.0; 30 min, 273.5
± 51.03; 60 min, 162.42 ± 19.68; 120 min, 47.43 ± 11.47
ng/ml).

View larger version (38K):
[in this window]
[in a new window]
|
Figure 1. The time course of plasma corticosterone response
to acute restraint in repeatedly restrained rats. C-rats were handled
daily. The time point on the x-axis represents the time after the onset
of the 90-min period of restraint on day 14. Values are presented as
means ± SEM. #, P < 0.05,
compared with 0 min; *, P < 0.01, compared with
control (one-way ANOVA followed by Fisher PLSD test).
|
|
Levels of CRH RNAs
Under basal conditions, CRH hnRNA expression was very low,
although CRH hnRNA transcripts can clearly be seen in the parvocellular
neurons of the hypothalamic PVN (Fig. 2a
). No silver grains were observed in
the parvocellular neurons hybridized with CRH sense riboprobe (Fig. 2b
). There was no significant difference between basal CRH hnRNA or
mRNA levels, after 13 days of repeated stress, and the levels found in
the control animals. After restraint, there was no significant increase
in either CRH hnRNA or mRNA levels in these repeatedly stressed animals
(Fig. 2
, C and D; Fig. 4
; also see Fig. 5
).

View larger version (119K):
[in this window]
[in a new window]
|
Figure 2. Effect of acute restraint on CRH hnRNA in the
hypothalamic PVN in daily handled control (A) and stressed rats (C, D).
Under unstressed conditions, CRH hnRNA expression is very low, but the
signal could be clearly seen in the medial parvocellular neurons of the
PVN (A). No labeled neurons were observed in the parvocellular PVN
hybridized with sense riboprobe, and the arrow points to
an example of an unlabeled nucleus (B). The level of CRH hnRNA in the
parvocellular neurons did not increase at 30 min (C) and 90 min (D)
after the onset of the last period of stress. Magnification, x400.
|
|

View larger version (152K):
[in this window]
[in a new window]
|
Figure 4. Effect of acute restraint on CRH mRNA and AVP mRNA
in the parvocellular subdivision of the PVN in daily handled control
and stressed rats. The level of CRH mRNA in the parvocellular neurons
of the PVN did not significantly increase at 4 h after the onset
of the last period of restraint (B), compared with daily handed control
(A). However, the level of AVP mRNA in the medial parvocellular (MP)
neurons of the PVN significantly increased and peaked at 3 h after
the onset of the last period of restraint (D), compared with daily
handed control (C). PM, Posterior magnocellular subdivision of the PVN.
3V, Third ventricle. Magnification: AB, x63; CD, x100.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Figure 5. The time course of CRH hnRNA and mRNA in the PVN
response to acute restraint in repeatedly restrained rats. C-rats were
handled daily. The time point on the x-axis represents the time after
the onset of the 90-min period of restraint on day 14. Changes of CRH
hnRNA or mRNA levels were not detected at any time point before or
after the onset of the last period of restraint. Values are presented
as means ± SEM (one-way ANOVA followed by Fisher PLSD
test).
|
|
Levels of AVP RNAs
AVP hnRNA expression in the parvocellular neurons of the
hypothalamic PVN were extremely low under normal unstressed conditions
(Fig. 3
, A and
B). There was no significant difference
between basal AVP hnRNA or mRNA levels in the parvocellular subdivision
of the PVN, after 13 days of repeated stress, and the levels found in
control animals. After restraint of these repeatedly stressed animals,
there was a very prompt increase in AVP hnRNA levels in the
parvocellular PVN, which was significant at 15 min, peaked at 60 and 90
min, and rapidly returned to basal levels at 2 h (within 30 min of
return to their home cage from the restrainer) (Fig. 3
, C and D; also
see Fig. 6
). AVP mRNA responded more slowly, reaching a significant
increase at 90 min and remaining raised at 4 h (Figs. 4
and 6
).

View larger version (128K):
[in this window]
[in a new window]
|
Figure 3. Effect of acute restraint on AVP hnRNA in the
parvocellular subdivision of the PVN in daily handled control (A, B)
and stressed rats (C, D). Under unstressed conditions, AVP hnRNA
expression is extremely low in medial parvocellular neurons (MP) of the
PVN (A, B). The level of AVP hnRNA in the parvocellular neurons
(small arrows) significantly increased and peaked at 60
min (C, D) after the onset of the last period of stress. PM, Posterior
magnocellular neurons (big arrows) of the PVN.
Magnification: A and C, x200; B and D, x400.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Figure 6. The time course of AVP hnRNA and mRNA in the
medial parvocellular subdivision of the PVN (parvoAVP hnRNA and
parvoAVP mRNA) response to acute restraint in repeatedly restrained
rats. C-rats were handled daily. The time point on the x-axis
represents the time after the onset of the 90-min period of restraint
on day 14. Values are presented as means ± SEM. *,
P < 0.05, compared with control; **,
P < 0.01, compared with control; #,
P < 0.05, compared with 0 min; ##,
P < 0.01, compared with 0 min (one-way ANOVA
followed by Fisher PLSD test).
|
|
Magnocellular PVN AVP hnRNA and mRNA were also measured throughout the
study. No changes in either RNA were found at any time point (Fig. 7
).

View larger version (22K):
[in this window]
[in a new window]
|
Figure 7. The time course of AVP hnRNA and mRNA in the
posterior magnocellular subdivision of the PVN (pmAVP hnRNA and pmAVP
mRNA) response to acute restraint in repeatedly restrained rats. C-rats
were handled daily. The time point on the x-axis represents time after
the onset of the 90-min period of restraint on day 14. The changes of
pmAVP hnRNA or mRNA contents were not detected at any time point before
or after the onset of the last period of restraint. Values are
presented as means ± SEM (one-way ANOVA followed by
Fisher PLSD test).
|
|
 |
Discussion
|
|---|
This study was designed to investigate the changes in hypothalamic
response that occur during the process of adaptation to repeated
stress. The response of the HPA to chronic or repeated stress varies
according to the type of stress (43). We have previously shown that the
response of parvocellular PVN CRH mRNA to daily restraint rapidly
desensitizes, with a complete loss of response occurring after 12 days
(14). Other stress paradigms provide different results, some resulting
in increased CRH mRNA levels in the PVN (19, 24, 26, 27, 28, 29, 44), whereas
chronic stress can decrease the level of CRH mRNA in the PVN (30).
These data suggest that the responses of CRH transcripts, in the PVN,
to repeated stress are stressor specific, and we therefore decided to
carry out a detailed investigation of a paradigm in which a degree of
adaptation was known to occur.
We chose the simple stimulus of daily restraint and carried out these
studies in the Wistar strain of rat, which has been extensively studied
in stress research and which has very similar CRH mRNA, AVP mRNA,
proenkephalin A mRNA, and corticosterone responses to the other
frequently studied strain (the Sprague-Dawley) (16). We have previously
shown that in naive Wistar rats, acute restraint stress results in a
very rapid increase of CRH hnRNA level, to more than 1,000% (as
reflected by probe binding) of control values, with CRH mRNA only
increasing significantly at 4 h. AVP hnRNA approximately doubled
at 60 min, and AVP mRNA showed a significant increase at 4 h (20).
After 13 days of restraint, we found a very marked change in the
pattern of the hypothalamic response to stress. The CRH hnRNA and mRNA
responses were completely abolished, whereas the response of AVP gene
transcription showed no diminution and, if anything, increased. AVP
hnRNA was significantly elevated within 15 min and was increased about
3-fold at 60 and 90 min, before falling to baseline values at 2 h
(just 30 min after the animal returned to its home cage). AVP mRNA was
significantly increased by 90 min and remained raised up to 4 h,
reaching peak levels of approximately 3 times basal value. The
up-regulation of parvocellular AVP gene transcription in this
experimental model is consistent with previous studies showing that
parvocellular AVP mRNA levels rise significantly after repeated
immobilization (19, 27) or repeated foot shock (44). The response does,
however, differ from that seen after multiple varied stressors, which
would not be expected to result in the same degree of adaptation (26).
These data suggest that AVP synthesized in the parvocellular PVN plays
an important role in activating the HPA axis under conditions of
chronic stress and may be necessary for the resistance of the HPA axis
to adaptation in response to such repeated stress (9).
The significant increase of AVP transcription, but not CRH
transcription, in the parvocellular PVN represents a remarkable
transcript-specific alteration in gene regulation and supports the
hypothesis that parvocellular AVP and CRH gene expression in the PVN
may have quite different transcriptional control mechanisms (26). It is
interesting that vasopressin-immunoreactive parvocellular neurons in
the PVN are identical to CRH neurons, and vasopressin-positive
parvocellular neurons are always stained for CRH (45, 46). Under normal
resting conditions, AVP is expressed in a subpopulation of CRH-positive
neurons in the PVN and colocalizes with approximately 50% of
CRH-positive terminals in the median eminence (6, 7). Repeated
immobilization increases the proportion of CRH parvocellular neurons
containing AVP to 90% and results in a 2-fold increase in the number
of AVP positive parvocellular neurons, whereas the number of CRH
parvocellular neurons remains at a normal level (27). In addition,
repeated immobilization does not affect CRH stores but significantly
increases the AVP stores and colocalization of AVP with CRH in the
median eminence (34). The proportion of CRH-expressing cells in the
parvocellular PVN that also express AVP increases substantially in
response to repeated stress (35). Furthermore, repeated
immobilization induces an increase in AVP-binding affinity and AVP V1b
receptor mRNA in the pituitary (47). Our results, taken together with
these published data, suggest that repeated restraint does activate CRH
parvocellular neurons to express AVP but not CRH (an adaptive change
whose mechanism is not understood).
Another interesting result is the fact that after repeated restraint,
there is still a marked corticosterone response to stress, in the
absence of any change in hypothalamic CRH gene transcription. Although
we cannot be sure that the lack of change in CRH RNA reflects lack of
peptide release from the median eminence, we have shown previously that
the reduction of CRH mRNA in chronic arthritis does correlate with
reduced levels of hypothalamic pituitary portal CRH-41 (30). It
certainly seems likely that the HPA response seen in our repeated
restraint paradigm results predominantly from the hypothalamic release
of AVP rather than CRH.
In conclusion, after a repeated restraint, there is a
transcript-specific alteration in gene regulation within the
parvocellular cells of the PVN, in which CRH gene transcription is
desensitized, but AVP gene transcription is maintained. These data
provide further evidence of the importance of AVP in the activation of
the HPA axis during chronic or repeated stress.
 |
Acknowledgments
|
|---|
The authors would like to thank Dr. Greti Aguilera for her
support and suggestions in the preparation of this manuscript, and
Susan Wood for her help in measuring plasma corticosterone
concentration.
 |
Footnotes
|
|---|
1 This work was supported by a grant from the Neuroendocrinology
Charitable Trust (to X.-M.M.). 
2 Present address: Xin-Ming Ma, Developmental Endocrinology Branch,
National Institute of Child Health and Human Development, National
Institute of Health, Building 10, Room 10N262, Bethesda, Maryland
20892. 
Received April 24, 1997.
 |
References
|
|---|
-
Antoni FA 1986 Hypothalamic control of
adrenocorticotropin secretion: advances since the discovery of
41-residue corticotropin-releasing factor. Endocr Rev 7:351378[CrossRef][Medline]
-
Antoni FA 1993 Vasopressinergic control of
pituitary adrenocorticotropin secretion comes of age. Front
Neuroendocrinol 14:76122[CrossRef][Medline]
-
Lightman SL, Harbuz MS, Knight RA, Chowdrey HS 1993 CRH mRNA in normal and stress conditions. Ann NY Acad Sci 698:2838
-
Rivier CL, Plotsky PM 1986 Mediation by
corticotrophin releasing factor (CRF) of adenohypophysial hormone
secretion. Annu Rev Physiol 48:475494[CrossRef][Medline]
-
Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson
L, Bilezikjian L, Bloom F, Rivier J 1983 Chemical and biological
characterization of corticotropin releasing factor. Recent Prog Horm
Res 39:245270
-
Whitnall MH, Smith D, Gainer H 1987 Vasopressin
coexists in half of the corticotropin-releasing factor axons present in
the external zone of the median eminence in normal rats.
Neuroendocrinology 45:420424[Medline]
-
Wolfson B, Manning RW, Davis LG, Arentzen R, Baldino Jr
F 1985 Colocalization of corticotropin-releasing factor (CRF), and
vasopressin mRNA in neurons after adrenalectomy. Nature 315:5961[CrossRef][Medline]
-
Whitnall MH 1993 Regulation of the hypothalamic
corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 40:573629[Medline]
-
Scaccianoce S, Muscolo LAA, Cigliana G, Navarra D,
Nicolai R, Angelucci L 1991 Evidence for a specific role of
vasopressin in sustaining pituitary-adrenocortical stress response in
the rat. Endocrinology 128:31383143[Abstract]
-
Liu J-P, Clarke IJ, Funder JW, Engler D 1990 The
biosynthesis and secretion of adrenocorticotropin by the ovine anterior
pituitary is predominantly regulated by arginine vasopressin (AVP).
J Biol Chem 2651:1413614142
-
Rivier C, Rivier J, Mormede P, Vale W 1984 Studies
of the nature of the interaction between vasopressin and
corticotropin-releasing factor in adrenocorticotropin release in rat.
Endocrinology 115:882886[Abstract]
-
Gillies GE, Linton EA, Lowry PJ 1982 Corticotropin
releasing activity of the new CRF is potentiated several times by
vasopressin. Nature 299:355357[CrossRef][Medline]
-
Lightman SL, Young III WS 1988 Corticotropin-releasing factor, vasopressin and pro-opiomelanocortin
mRNA responses to stress and opiates in the rats. J Physiol (Lond) 403:511523[Abstract/Free Full Text]
-
Lightman SL, Harbuz MS 1993 Expression of
corticotropin releasing factor mRNA in response to stress. In: Chadwick
DJ, Marsh J, Ackill K (eds) Corticotropin-Releasing Factor. Wiley,
Chichester, UK, pp 173188
-
Harbuz MS, Lightman SL 1988 Response of
hypothalamus and pituitary mRNA to physiological stress in the rat. J
Endocrinol 122:705711
-
Harbuz MS, Jessop DS, Lightman SL, Chowdrey HS 1994 The effect of restraint or hypertonic saline stress on
corticotropin-releasing factor, arginine vasopressin, and proenkephalin
A mRNAs in the CFY, Sprague and Wistar strains of rat. Brain Res 667:612[CrossRef][Medline]
-
Imaki T, Shibasaki T, Hotta M, Demura H 1992 Early
induction of c-fos precedes increased expression of
corticotropin-releasing factor messenger ribonucleic acid in the
paraventricular nucleus after immobilization stress. Endocrinology 132:240246
-
Kalin NH, Takahashi LK, Chen F-L 1994 Restraint
stress increases corticotropin-releasing hormone mRNA content in the
amygdala and paraventricular nucleus. Brain Res 656:182186[CrossRef][Medline]
-
Makino S, Smith MA, Gold PW 1995 Increased
expression of corticotropin-releasing hormone and vasopressin messenger
ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus
during repeated stress: association with reduction in glucocorticoid
receptor mRNA levels. Endocrinology 136:32993309[Abstract]
-
Ma X-M, Levy A, Lightman SL 1997 Rapid changes in
heteronuclear RNA for corticotropin-releasing hormone and arginine
vasopressin in response to acute stress. J Endocrinol 152:8189[Abstract/Free Full Text]
-
Darlington DN, Barraclough CA, Gann DS 1992 Hypotensive hemorrhage elevates corticotropin-releasing hormone
messenger ribonucleic acid (mRNA) but not vasopressin mRNA in the rat
hypothalamus. Endocrinology 130:12811288[Abstract]
-
Bartanusz V, Aubry J-M, Steimer T, Baffi J, Kiss JZ 1994 Stressor-specific increase of vasopressin mRNA in paraventricular
hypophysiotrophic neurons. Neurosci Lett 170:3538[CrossRef][Medline]
-
Herman JP 1995 In situ hybridization
analysis of vasopressin gene transcription in the paraventricular and
supraoptic nuclei of the rat: regulation by stress and glucocorticoids.
J Comp Neurol 363:1527[CrossRef][Medline]
-
Lightman SL, Young III WS 1989 Influence of
steroids on the hypothalamic corticotropin-releasing factor and
preproenkephalin mRNA responses to stress. Proc Natl Acad Sci USA 86:43064130[Abstract/Free Full Text]
-
Herman JP, Schafer MK-H, Sladek CD, Day R, Young EA,
Akil H, Watson SJ 1989 Chronic electroconvulsive shock treatment
elicits up regulation of CRH and AVP in select populations of
neuroendocrine neurons. Brain Res 501:235246[CrossRef][Medline]
-
Herman JP, Adams D, Prewitt C 1995 Regulatory
changes in neuroendocrine stress-integrative circuitry produced by a
variable stress paradigm. Neuroendocrinology 61:180190[CrossRef][Medline]
-
Bartanusz V, Jezova D, Bertini LT, Tilders FJH, Aubry
JM, Kiss JZ 1993 Stress-induced increase in vasopressin and
corticotropin-releasing factor expression in hypophysiotrophic
paraventricular neurons. Endocrinology 132:895902[Abstract]
-
Mamalaki E, Kvetnansky R, Brady LS, Gold PV, Herkenham
M 1992 Repeated immobilization stress alters tyrosine hydroxylase,
corticotropin-releasing hormone and corticosteroid receptor messenger
ribonucleic acid levels in rat brain. J Neuroendocrinol
4/5:689699
-
Gomez F, Lahmame A, de Kloet ER, Armario A 1996 Hypothalamic-pituitary-adrenal response to chronic stress in five
inbred rat strains: differential response are mainly located at the
adrenocortical level. Neuroendocrinology 63:327337[Medline]
-
Harbuz MS, Rees RG, Eckland D, Jessop DS, Brewerton D,
Lightman SL 1992 Paradoxical response of Hypothalamic
corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA)
and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during
chronic inflammatory stress. Endocrinology 130:13941400[Abstract]
-
Hauger RL, Millan MA, Lorang M, Harwood JP, Aguilera
G 1988 Corticotropin-releasing factor receptor and pituitary
adrenal responses during immobilization stress. Endocrinology 123:396405[Abstract]
-
Hauger RL, Millan MA, Lorang M, Irwin M, Aguilera G 1990 CRF receptor regulation and sensitization of ACTH responses to
acute stress during chronic stress intermitted immobilization stress.
Brain Res 532:3440[CrossRef][Medline]
-
Hashimoto K, Suemaru S, Takao T, Sugawara M, Makino S,
Ota Z 1988 Corticotropin-releasing hormone and pituitary
adrenocortical responses in chronically stressed rat. Regul Pept 23:117126[CrossRef][Medline]
-
deGoeij DEC, Kvetnansky R, Whitnall MH, Jezova D,
Berkenbosch F, Tilders FJH 1991 Repeated stress-induced
activation of corticotropin-releasing factor neurons enhances
vasopressin stores and colocalization with corticotropin releasing
factor neurons in the median eminence of rats. Neuroendocrinology 53:150159[Medline]
-
deGoeij DEC, Jezova D, Tilders FJH 1992 Repeated
stress enhances vasopressin synthesis in corticotropin releasing factor
neurons in the paraventricular nucleus. Brain Res 577:165168[CrossRef][Medline]
-
Priou A, Oliver C, Grino M 1993 In situ
hybridization of arginine vasopressin (AVP) heteronuclear ribonucleic
acid reveals increased AVP gene transcription in the rat hypothalamic
paraventricular nucleus in response to emotional stress. Acta
Endocrinol (Copenh) 128:466472[Medline]
-
Imaki T, Wang X-Q, Shibasaki T, Yamada K, Harada S,
Chikada N, Naruse M, Demura H 1995 Stress-induced activation of
neuronal activity and corticotropin-releasing factor gene expression in
the paraventricular nucleus is modulated by glucocorticoid in rats.
J Clin Invest 96:231238
-
Kovcs KJ, Sawchenko PE 1996 Sequence of
stress-induced alterations in indices of synaptic and transcriptional
activation in parvocellular neurosecretory neurons. J Neurosci 16:262273[Abstract/Free Full Text]
-
Schmale H, Heisohn S, Richter D 1983 Structural
organization of the rat gene for the arginine vasopressin-neurophysin
precursor. EMBO J 2:763767[Medline]
-
Young III WS, Mezey E, Siegel RE 1986 Quantitative
in situ hybridization histochemistry reveals increased
levels of corticotropin-releasing factor mRNA after adrenalectomy in
rats. Neurosci Lett 70:231241
-
Thompson RC, Seasholtz AF, Herbert E 1987 Rat
corticotropin-releasing hormone gene: sequence and tissue-specific
expression. Mol Endocrinol 1:363370[CrossRef][Medline]
-
Herman JP, Schafer MKH, Thompson RC, Watson SL 1992 Rapid regulation of corticotropin-releasing hormones gene transcription
in vivo. Mol Endocrinol 6:10611069[Abstract]
-
Aguilera G 1994 Regulation of pituitary ACTH
secretion during chronic stress. Front Neuroendocrinol 15:321350[CrossRef][Medline]
-
Sawchenko PE, Arias CA, Mortrud MT 1993 Local
tetrodoxin blocks chronic stress effects on corticotropin-releasing
factor and vasopressin messenger ribonucleic acid in hypophysiotropic
neurons. J Neuroendocrinol 5:341348[CrossRef][Medline]
-
Kiss JZ, Mezey E, Skirboll L 1984 Corticotropin-releasing factor immuno-reactive neurons of the
paraventricular nucleus become vasopressin positive after
adrenalectomy. Prol Natl Acad Sci USA 84:18541858
-
Sawchenko PE, Swanson LW, Vale W 1987 Co-expression
of corticotropin-releasing factor and vasopressin immunoreactivity in
parvocellular neurosecretory neurons of the adrenalectomized rat. Proc
Natl Acad Sci USA 81:18831887
-
Rabadan-Diehl C, Lolait SJ, Aguilera G 1995 Regulation of pituitary vasopressin V1b receptor mRNA during stress in
rat. J Neuroendocrinol 7:903- 910[CrossRef][Medline]
This article has been cited by other articles:

|
 |

|
 |
 
C. J. Rice, C. A. Sandman, M. R. Lenjavi, and T. Z. Baram
A Novel Mouse Model for Acute and Long-Lasting Consequences of Early Life Stress
Endocrinology,
October 1, 2008;
149(10):
4892 - 4900.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. E. Bates, A. S. Sirek, M. A. Kiraly, J. T. Y. Yue, D. Goche Montes, S. G. Matthews, and M. Vranic
Adaptation to Mild, Intermittent Stress Delays Development of Hyperglycemia in the Zucker Diabetic Fatty Rat Independent of Food Intake: Role of Habituation of the Hypothalamic-Pituitary-Adrenal Axis
Endocrinology,
June 1, 2008;
149(6):
2990 - 3001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Subburaju and G. Aguilera
Vasopressin Mediates Mitogenic Responses to Adrenalectomy in the Rat Anterior Pituitary
Endocrinology,
July 1, 2007;
148(7):
3102 - 3110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yao, M. Stenzel-Poore, and R. J. Denver
Structural and Functional Conservation of Vertebrate Corticotropin-Releasing Factor Genes: Evidence for a Critical Role for a Conserved Cyclic AMP Response Element
Endocrinology,
May 1, 2007;
148(5):
2518 - 2531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Lolait, L. Q. Stewart, D. S. Jessop, W. S. Young 3rd, and A.-M. O'Carroll
The Hypothalamic-Pituitary-Adrenal Axis Response to Stress in Mice Lacking Functional Vasopressin V1b Receptors
Endocrinology,
February 1, 2007;
148(2):
849 - 856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kawasaki, T. Onaka, M. Nakazato, J. Saito, T. Mera, H. Hashimoto, H. Fujihara, N. Okimoto, H. Ohnishi, T. Nakamura, et al.
Centrally administered neuropeptide W-30 activates magnocellular neurosecretory cells in the supraoptic and paraventricular nuclei with neurosecretion in rats.
J. Endocrinol.,
August 1, 2006;
190(2):
213 - 223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Park, O. Chan, Q. Li, M. Kiraly, S. G. Matthews, M. Vranic, and M. C. Riddell
Changes in basal hypothalamo-pituitary-adrenal activity during exercise training are centrally mediated
Am J Physiol Regulatory Integrative Comp Physiol,
November 1, 2005;
289(5):
R1360 - R1371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Chan, K. Inouye, E. M. Akirav, E. Park, M. C. Riddell, S. G. Matthews, and M. Vranic
Hyperglycemia does not increase basal hypothalamo-pituitary-adrenal activity in diabetes but it does impair the HPA response to insulin-induced hypoglycemia
Am J Physiol Regulatory Integrative Comp Physiol,
July 1, 2005;
289(1):
R235 - R246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Vandenborne, B. De Groef, S. M. E. Geelissen, G. C. Boorse, R. J. Denver, E. R. Kuhn, V. M. Darras, and S. Van der Geyten
Molecular Cloning and Developmental Expression of Corticotropin-Releasing Factor in the Chicken
Endocrinology,
January 1, 2005;
146(1):
301 - 308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zelena, Z. Mergl, A. Foldes, K. J. Kovacs, Z. Toth, and G. B. Makara
Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint
Am J Physiol Endocrinol Metab,
November 1, 2003;
285(5):
E1110 - E1117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. H. Burbach, S. M. Luckman, D. Murphy, and H. Gainer
Gene Regulation in the Magnocellular Hypothalamo-Neurohypophysial System
Physiol Rev,
July 1, 2001;
81(3):
1197 - 1267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Kovacs, A. Foldes, and P. E. Sawchenko
Glucocorticoid Negative Feedback Selectively Targets Vasopressin Transcription in Parvocellular Neurosecretory Neurons
J. Neurosci.,
May 15, 2000;
20(10):
3843 - 3852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-M. Ma, S. L. Lightman, and G. Aguilera
Vasopressin and Corticotropin-Releasing Hormone Gene Responses to Novel Stress in Rats Adapted to Repeated Restraint
Endocrinology,
August 1, 1999;
140(8):
3623 - 3632.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Ferin
Stress and the Reproductive Cycle
J. Clin. Endocrinol. Metab.,
June 1, 1999;
84(6):
1768 - 1774.
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Bonaz and S. Rivest
Effect of a chronic stress on CRF neuronal activity and expression of its type 1 receptor in the rat brain
Am J Physiol Regulatory Integrative Comp Physiol,
November 1, 1998;
275(5):
R1438 - R1449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Xiao, L. Xia-Zhang, A. Barth, J. Zhu, and M. Ferin
Stress and the Menstrual Cycle: Relevance of Cycle Quality in the Short- and Long-Term Response to a 5-Day Endotoxin Challenge during the Follicular Phase in the Rhesus Monkey
J. Clin. Endocrinol. Metab.,
July 1, 1998;
83(7):
2454 - 2460.
[Abstract]
[Full Text]
|
 |
|